Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DASATINIB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05433896
What this trial is testing

Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions

Who this might be right for
PharmacokineticsDrug Interactions
Xspray Pharma AB 17
Not applicableStudy completedNCT02546791
What this trial is testing

Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study

Who this might be right for
Leukemia
Bristol-Myers Squibb 101
Early research (Phase 1)Study completedNCT00940524
What this trial is testing

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaAcute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00438854
What this trial is testing

Dasatinib in Relapsed Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Massachusetts General Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00459342
What this trial is testing

Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 35
Not applicableUnknownNCT05042531
What this trial is testing

Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
LanZhou University 30
Testing effectiveness (Phase 2)UnknownNCT04284202
What this trial is testing

PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC

Who this might be right for
NSCLC Stage IVARID1APD-1
The Affiliated Hospital of Qingdao University 30
Early research (Phase 1)Study completedNCT01644773
What this trial is testing

Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)

Who this might be right for
Diffuse Intrinsic Pontine GliomaHigh-grade Glioma
St. Jude Children's Research Hospital 36
Testing effectiveness (Phase 2)Study completedNCT00436605
What this trial is testing

Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
National Cancer Institute (NCI) 39
Not applicableNo Longer AvailableNCT00454753
What this trial is testing

Expanded Access for Dasatinib

Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00816283
What this trial is testing

Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 5
Post-approval studies (Phase 4)Study completedNCT04925141
What this trial is testing

Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

Who this might be right for
Chronic Myelogenous Leukemia - Chronic Phase
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 62
Early research (Phase 1)Looking for participantsNCT03595917
What this trial is testing

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL
Marlise Luskin, MD 40
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Ended earlyNCT02709083
What this trial is testing

Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous LeukemiaChronic Myeloid LeukemiaLeukemia
Emory University 7
Testing effectiveness (Phase 2)Study completedNCT00696072
What this trial is testing

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic

Who this might be right for
Metastatic Breast Cancer
Bristol-Myers Squibb 120
Testing effectiveness (Phase 2)Study completedNCT00570700
What this trial is testing

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Who this might be right for
Hormone-refractory Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
University of California, Irvine 38
Early research (Phase 1)Study completedNCT00103701
What this trial is testing

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic-phaseLeukemia, Lymphoblastic, Acute, Philadelphia-positive
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00316953
What this trial is testing

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+5 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Ended earlyNCT02047149
What this trial is testing

Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
University of Massachusetts, Worcester 2
Next Page